ERBB2 and breast carcinoma: Hans and colleagues cultured a library of over 100 primary and metastatic breast cancer organoids, confirming that they match the original tumors closely in terms of histopathological subtype, hormone receptor status, and human epidermal growth factor receptor 2(HER2) status.